MiR‐545 inhibits EGFR expression and pancreatic ductal adenocarcinoma growth by targeting RIG‐I 38, 39 and enhances radiosensitivity by suppressing Ku70 expression in a Lewis lung carcinoma xenograft model 40. Here, EGFR is linked to pancreatic ductal adenocarcinoma.